UCSF’s Yamamoto Talks Pharma Partnering

Yesterday brought news that Keith Yamamoto has been named vice chancellor of research at University of California, San Francisco, where the pharmacologist has long been vice dean of the School of Medicine. Coincidentally, this week’s issue includes a one-on-one with Yamamoto, who is playing an instrumental role in reshaping the model for industry and academia partnerships. In the story, we pick Yamamoto’s brain about the genesis of...

Read More

Pfizer Adds UCSF as First Partner in Academic Network

Pfizer has committed up to $85 million over five years to an expansive research agreement with the University of California, San Francisco, intended to speed the development of new biologic-based medications. More critically, the relationship with UCSF will be the first spoke in a network of academic collaborators, with Pfizer at the hub. Called the Center for Therapeutic Innovation, the goal is to bridge the gap between basic science...

Read More